IRCT20180103038196N8已完成2 期
Comparative study of two doses of filgrastim (5 and 15 Microgram/ kg) on the absolute neutrophil count in children with cancer
Gorgan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 14 years（—）
- 性别
- All
入选标准
- •patients with cancer associated with neutropenia
- •Parents' informed consent for their child's participation in the study
- •patients with absolute neutrophil count<1500 with one of the following items:
- •Neutropenia lasts for more than 7-10 days
- •Low blood pressure
- •Profound neutropenia
- •fungal infections
排除标准
- •Patients with less than 1500 neutrophils while they have active leukemia or their leukemia is not in the remission phase.
研究者
相似试验
已完成
2 期
The comparison of effects of two drugs in neutropenic patientseutropenia.NeutropeniaIRCT201205279875N1Cinnagen Drug Corporation66
尚未招募
3 期
Comparison of the effect of pegfilgrastim with filgrastim on the neutrophil count of cancer patients under chemotherapy.IRCT20180119038433N3Semnan University of Medical Sciences60
已完成
1 期
The effect of filgrastim and pegfilgrastim in the treatment of fever and immune deficiencyIschemic stroke.Cerebral infarctionIRCT20130812014333N80Vice chancellor for research, Kermanshah University of Medical Sciences100
进行中（未招募）
1 期
Evaluating the Therapeutic Efficacy of Filgrastim in Severe Bullous Drug Eruptions (Lyell and Stevens-Johnson Syndromes)CTIS2024-515275-35-00Hospices Civils De Lyon42
进行中（未招募）
不适用
Pegfilgrastim versus filgrastim after high-dose chemotherapy followed by autologous peripheral blood stem cell, in patients with hematologic and solid tumors a randomized phase II study - NDPatients with hematological neoplasia or solid tumors treated with high-dose chemotherapyMedDRA version: 6.1Level: HLGTClassification code 10027655EUCTR2006-001409-27-ITISTITUTO CLINICO HUMANITAS80